Srivastava Leads Research at New England Peptide

Mass High Tech


February 16, 2009


By Ernie King - News Staff Writer

New England Peptide LLC has appointed former NEP board member Ved Srivastava as vice president for research production, where he will oversee the company production pipeline, officials reported.

Srivastava joins NEP from his former role as associate director of discovery research at Amylin Pharmaceuticals Inc. In that role, he led the discovery, synthesis and development of peptide hormones used for obesity, diabetes and neuropsychiatric treaments. His chemistry management skills also led Srivastava to direct research for Psylin Neurosciences Inc., the joint venture of Amylin and PsychoGenesis Inc.

Srivastava graduated from India’s University of Lucknow with a doctoral degree in organic chemistry. Since then, he’s held post-doctoral roles at the University of Georgia and the University of Colorado medical school.

Founded in 1998, Gardner-based NEP makes peptides used globally in drug and vaccine antibodies.


"THANKS AGAIN for all the intellectual support that NEP has provided to us over the last year. My colleagues have been overwhelmingly impressed with the quality of service and level of thought that you have put into researching and thinking about our particular peptide and antibody production needs. The level of scholarship went well beyond what we expected from any peptide and antibody company, and was crucial in shaping our decisions. It has truly been a pleasure corresponding with you."
Cliff N. PhD - Lawrence Berkeley National Laboratory